Improved estimation of time-varying reproduction numbers at low case incidence and between epidemic waves.


Journal

PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922

Informations de publication

Date de publication:
09 2021
Historique:
received: 05 10 2020
accepted: 13 08 2021
revised: 17 09 2021
pubmed: 8 9 2021
medline: 15 12 2021
entrez: 7 9 2021
Statut: epublish

Résumé

We construct a recursive Bayesian smoother, termed EpiFilter, for estimating the effective reproduction number, R, from the incidence of an infectious disease in real time and retrospectively. Our approach borrows from Kalman filtering theory, is quick and easy to compute, generalisable, deterministic and unlike many current methods, requires no change-point or window size assumptions. We model R as a flexible, hidden Markov state process and exactly solve forward-backward algorithms, to derive R estimates that incorporate all available incidence information. This unifies and extends two popular methods, EpiEstim, which considers past incidence, and the Wallinga-Teunis method, which looks forward in time. We find that this combination of maximising information and minimising assumptions significantly reduces the bias and variance of R estimates. Moreover, these properties make EpiFilter more statistically robust in periods of low incidence, where several existing methods can become destabilised. As a result, EpiFilter offers improved inference of time-varying transmission patterns that are advantageous for assessing the risk of upcoming waves of infection or the influence of interventions, in real time and at various spatial scales.

Identifiants

pubmed: 34492011
doi: 10.1371/journal.pcbi.1009347
pii: PCOMPBIOL-D-20-01808
pmc: PMC8448340
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009347

Subventions

Organisme : Medical Research Council
ID : MC_PC_19012
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J R Soc Interface. 2019 Jan 31;16(150):20180670
pubmed: 30958162
Syst Biol. 2020 Nov 1;69(6):1163-1179
pubmed: 32333789
PLoS Comput Biol. 2020 Nov 30;16(11):e1008478
pubmed: 33253158
Am J Epidemiol. 2004 Sep 15;160(6):509-16
pubmed: 15353409
Epidemics. 2015 Mar;10:54-7
pubmed: 25843384
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
PLoS Comput Biol. 2019 Feb 11;15(2):e1006785
pubmed: 30742608
Proc Biol Sci. 2020 Aug 12;287(1932):20201405
pubmed: 32781946
J R Soc Interface. 2021 Dec;18(185):20210569
pubmed: 34905965
PLoS Comput Biol. 2017 Oct 27;13(10):e1005687
pubmed: 29077703
Lancet Public Health. 2020 Nov;5(11):e612-e623
pubmed: 33065023
Am J Epidemiol. 2006 Sep 15;164(6):591-7
pubmed: 16887892
Biometrics. 2020 Sep;76(3):677-690
pubmed: 32277713
Euro Surveill. 2020 Apr;25(17):
pubmed: 32372755
Proc Biol Sci. 2007 Feb 22;274(1609):599-604
pubmed: 17476782
Infect Dis Model. 2017 Mar 11;2(2):128-142
pubmed: 29928733
PLoS One. 2007 Aug 22;2(8):e758
pubmed: 17712406
Nature. 2020 Aug;584(7821):420-424
pubmed: 32674112
PLoS Comput Biol. 2020 Dec 10;16(12):e1008409
pubmed: 33301457
PLoS Comput Biol. 2014 Dec 04;10(12):e1003942
pubmed: 25473849
Sci Data. 2015 May 26;2:150019
pubmed: 26029377
Lancet Infect Dis. 2021 Feb;21(2):193-202
pubmed: 33729915
Lancet. 2020 May 9;395(10235):1474
pubmed: 32386582
PLoS Comput Biol. 2020 Jul 1;16(7):e1007990
pubmed: 32609732
N Engl J Med. 2014 Oct 16;371(16):1481-95
pubmed: 25244186
Science. 2014 Jun 13;344(6189):1230-2
pubmed: 24926005
Syst Biol. 2018 Jul 1;67(4):719-728
pubmed: 29432602
Epidemics. 2018 Mar;22:29-35
pubmed: 28351674
Bull Math Biol. 2020 Apr 8;82(4):52
pubmed: 32270376
Epidemics. 2015 Mar;10:68-71
pubmed: 25843387
Syst Biol. 2021 Dec 16;71(1):121-138
pubmed: 33989428
Bioinformatics. 2018 Nov 1;34(21):3638-3645
pubmed: 29718104
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12680-12685
pubmed: 30463945
Am J Epidemiol. 2013 Nov 1;178(9):1505-12
pubmed: 24043437
Sci Data. 2020 Oct 8;7(1):345
pubmed: 33033256

Auteurs

Kris V Parag (KV)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH